PubMed COVID-19 Clinical Care

CONCLUSIONS: COVID-19 is associated with an increased risk of developing autoimmune diseases in the Japanese population, and this effect persists for a long time. This study provides insights into the association between viral infections and

CONCLUSION: We provide a new perspective on the interactive effects of organizational climate and political partisanship on attitudes to vaccines. Our research suggests that, when it comes to vaccine readiness, it is precisely those who are most

Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a lifesaving technique for patients experiencing respiratory failure. When VV ECMO fails to provide adequate support despite optimal settings, alternative strategies may be employed. One

Currently, worldwide, the coronavirus disease 2019 (COVID-19) pandemic, which first appeared in Wuhan, China, in December 2019, is capsizing the medical system and turning the attention of the entire healthcare system through the many aspects it

CONCLUSIONS: PTSD rate were similar between groups. Adaptive ways of communication, restricted visits and global uncertainties could explain the absence of differences.

CONCLUSIONS: Our findings highlight the need to incentivize healthcare professionals and pediatricians to inform parents about vaccines, clarify misconceptions and address concerns.

CONCLUSION: Counseling activities and toolkits provided in the manual were effective in reduction of psychological distress in children during COVID-19 pandemic.

The COVID-19 pandemic and lockdowns had significant impacts on sexual functioning and behavior. Partnered sexual activity decreased overall, while solo sex activities such as masturbation and pornography consumption increased exponentially. Given the

A total of 320 children, aged 1 to 14 years were observed to ascertain the prevalence of face mask usage and the factors affecting the same. 67% of children used face masks, but only 25% of them used them correctly. Factors such as age, type of

We evaluated the population-level benefits of expanding treatment with the antiviral drug Paxlovid (nirmatrelvir/ritonavir) in the United States for SARS-CoV-2 Omicron variant infections. Using a multiscale mathematical model, we found that treating